Director Marvin White (NYSE: EBS) receives RSU and stock option awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Emergent BioSolutions Inc. reported that director Marvin L. White received equity compensation on April 30, 2026. He was granted 25,344 restricted stock units for Board and Committee service, each RSU representing one share of common stock upon vesting.
He also received 11,296 stock options, each allowing the purchase of one common share at an exercise price of $7.99 per share. Both the RSUs and options vest on the day prior to the one-year anniversary of the grant date, contingent on his continued board service. After these awards, he directly holds 113,839 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
White Marvin L
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 11,296 | $0.00 | -- |
| Grant/Award | Common Stock | 25,344 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 11,296 shares (Direct, null);
Common Stock — 113,839 shares (Direct, null)
Footnotes (1)
- Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the Reporting Person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price. The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.
Key Figures
RSUs granted: 25,344 units
Stock options granted: 11,296 options
Option exercise price: $7.99 per share
+2 more
5 metrics
RSUs granted
25,344 units
Annual grant for Board and Committee service on April 30, 2026
Stock options granted
11,296 options
Annual grant for Board and Committee service on April 30, 2026
Option exercise price
$7.99 per share
Exercise price for newly granted stock options
Shares after transaction
113,839 shares
Common stock directly held by Marvin L. White after awards
Option expiration
April 30, 2033
Expiration date for newly granted stock options
Key Terms
restricted stock units ("RSUs"), Stock Option (Right to Buy), Stock Incentive Plan, Black-Scholes value
4 terms
restricted stock units ("RSUs") financial
"Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive Plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (Right to Buy) financial
"Consists of stock options granted under the Company's Stock Incentive Plan"
Stock Incentive Plan financial
"granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
Black-Scholes value financial
"dividing by the Black-Scholes value of a single option calculated as of the date of the grant"
FAQ
What equity awards did Marvin L. White receive from Emergent BioSolutions (EBS)?
Marvin L. White received 25,344 restricted stock units and 11,296 stock options as compensation for Board and Committee service. Each RSU converts into one common share upon vesting, and each option allows purchase of one share at a fixed exercise price.
When do Marvin L. White’s new Emergent BioSolutions (EBS) RSUs and options vest?
Both the RSUs and stock options vest on the day before the one-year anniversary of the April 30, 2026 grant date. Vesting is contingent on Marvin L. White remaining a member of Emergent BioSolutions’ board of directors through that Annual Grant Vesting Date.
What is the exercise price of Marvin L. White’s new Emergent BioSolutions (EBS) stock options?
The newly granted stock options have an exercise price of $7.99 per share. Each option allows Marvin L. White to purchase one share of Emergent BioSolutions common stock at this price once the options vest, provided he continues serving on the board.
Are Marvin L. White’s Emergent BioSolutions (EBS) transactions open-market buys or compensation grants?
These transactions are compensation-related grants, not open-market purchases or sales. The RSUs and stock options were awarded under Emergent BioSolutions’ Stock Incentive Plan for Board and Committee service, with vesting tied to his continued role as a director.